BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34738833)

  • 1. Preserved β-adrenergic-mediated vasodilation in skeletal muscle of young adults with obesity despite shifts in cyclooxygenase and nitric oxide synthase.
    Limberg JK; Johansson RE; Carter KJ; Peltonen GL; Harrell JW; Kellawan JM; Eldridge MW; Sebranek JJ; Walker BJ; Schrage WG
    Am J Physiol Heart Circ Physiol; 2022 Jan; 322(1):H25-H35. PubMed ID: 34738833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Adrenergic-mediated vasodilation in young men and women: cyclooxygenase restrains nitric oxide synthase.
    Limberg JK; Johansson RE; Peltonen GL; Harrell JW; Kellawan JM; Eldridge MW; Sebranek JJ; Schrage WG
    Am J Physiol Heart Circ Physiol; 2016 Mar; 310(6):H756-64. PubMed ID: 26747505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase and cyclooxygenase modulate β-adrenergic cutaneous vasodilatation and sweating in young men.
    Fujii N; McNeely BD; Kenny GP
    J Physiol; 2017 Feb; 595(4):1173-1184. PubMed ID: 27779753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandins do not contribute to the nitric oxide-mediated compensatory vasodilation in hypoperfused exercising muscle.
    Casey DP; Joyner MJ
    Am J Physiol Heart Circ Physiol; 2011 Jul; 301(1):H261-8. PubMed ID: 21536852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise vasodilation is greater in women: contributions of nitric oxide synthase and cyclooxygenase.
    Kellawan JM; Johansson RE; Harrell JW; Sebranek JJ; Walker BJ; Eldridge MW; Schrage WG
    Eur J Appl Physiol; 2015 Aug; 115(8):1735-46. PubMed ID: 25820143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-differences in cholinergic, nicotinic, and β-adrenergic cutaneous vasodilation: Roles of nitric oxide synthase, cyclooxygenase, and K
    Fujii N; McGarr GW; Ghassa R; Schmidt MD; McCormick JJ; Nishiyasu T; Kenny GP
    Microvasc Res; 2020 Sep; 131():104030. PubMed ID: 32531353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist-dependent variablity of contributions of nitric oxide and prostaglandins in human skeletal muscle.
    Schrage WG; Dietz NM; Eisenach JH; Joyner MJ
    J Appl Physiol (1985); 2005 Apr; 98(4):1251-7. PubMed ID: 15563630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preserved Microvascular Endothelial Function in Young, Obese Adults with Functional Loss of Nitric Oxide Signaling.
    Harrell JW; Johansson RE; Evans TD; Sebranek JJ; Walker BJ; Eldridge MW; Serlin RC; Schrage WG
    Front Physiol; 2015; 6():387. PubMed ID: 26733880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketorolac alters blood flow during normothermia but not during hyperthermia in middle-aged human skin.
    Holowatz LA; Jennings JD; Lang JA; Kenney WL
    J Appl Physiol (1985); 2009 Oct; 107(4):1121-7. PubMed ID: 19661446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of nitric oxide synthase and cyclooxygenase in leg vasodilation and oxygen consumption during prolonged low-intensity exercise in untrained humans.
    Schrage WG; Wilkins BW; Johnson CP; Eisenach JH; Limberg JK; Dietz NM; Curry TB; Joyner MJ
    J Appl Physiol (1985); 2010 Sep; 109(3):768-77. PubMed ID: 20558755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-mediated vasodilation becomes independent of beta-adrenergic receptor activation with increased intensity of hypoxic exercise.
    Casey DP; Curry TB; Wilkins BW; Joyner MJ
    J Appl Physiol (1985); 2011 Mar; 110(3):687-94. PubMed ID: 21193565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of ATP-mediated vasodilation in humans: modest role for nitric oxide and vasodilating prostaglandins.
    Crecelius AR; Kirby BS; Richards JC; Garcia LJ; Voyles WF; Larson DG; Luckasen GJ; Dinenno FA
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1302-10. PubMed ID: 21784984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of nitric oxide and prostaglandins in the hyperemic response to a maximal metabolic stimulus: redundancy prevails.
    Lopez MG; Silva BM; Joyner MJ; Casey DP
    Eur J Appl Physiol; 2013 Jun; 113(6):1449-56. PubMed ID: 23250568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contracting human skeletal muscle maintains the ability to blunt α1 -adrenergic vasoconstriction during KIR channel and Na(+) /K(+) -ATPase inhibition.
    Crecelius AR; Kirby BS; Hearon CM; Luckasen GJ; Larson DG; Dinenno FA
    J Physiol; 2015 Jun; 593(12):2735-51. PubMed ID: 25893955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.
    Lembo G; Iaccarino G; Vecchione C; Barbato E; Izzo R; Fontana D; Trimarco B
    J Clin Invest; 1997 Oct; 100(8):2007-14. PubMed ID: 9329964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the endothelium in the hyperemic response to passive leg movement: looking beyond nitric oxide.
    Trinity JD; Kwon OS; Broxterman RM; Gifford JR; Kithas AC; Hydren JR; Jarrett CL; Shields KL; Bisconti AV; Park SH; Craig JC; Nelson AD; Morgan DE; Jessop JE; Bledsoe AD; Richardson RS
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H668-H678. PubMed ID: 33306447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined inhibition of nitric oxide and vasodilating prostaglandins abolishes forearm vasodilatation to systemic hypoxia in healthy humans.
    Markwald RR; Kirby BS; Crecelius AR; Carlson RE; Voyles WF; Dinenno FA
    J Physiol; 2011 Apr; 589(Pt 8):1979-90. PubMed ID: 21486803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented skeletal muscle hyperaemia during hypoxic exercise in humans is blunted by combined inhibition of nitric oxide and vasodilating prostaglandins.
    Crecelius AR; Kirby BS; Voyles WF; Dinenno FA
    J Physiol; 2011 Jul; 589(Pt 14):3671-83. PubMed ID: 21624968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous nitric oxide contributes to bradykinin-stimulated glucose uptake but attenuates vascular tissue-type plasminogen activator release.
    Pretorius M; Brown NJ
    J Pharmacol Exp Ther; 2010 Jan; 332(1):291-7. PubMed ID: 19841473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOS inhibition blunts and delays the compensatory dilation in hypoperfused contracting human muscles.
    Casey DP; Joyner MJ
    J Appl Physiol (1985); 2009 Dec; 107(6):1685-92. PubMed ID: 19729589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.